New therapy with ASC-J9® to suppress the prostatitis via altering the cytokine CCL2 signals-Reference-Cited by-同舟云学术

New therapy with ASC-J9® to suppress the prostatitis via altering the cytokine CCL2 signals

Published:2016-08-22 Issue:41 Volume:7 Page:66769-66775
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Lin Shin-Jen¹,Chou Fu-Ju¹,Lin Chang-Yi¹,Chang Hong-Chiang¹,Yeh Shuyuan¹,Chang Chawnshang¹²

Affiliation:

1. George Whipple Laboratory for Cancer Research, Departments of Pathology, Urology, and Radiation Oncology, and Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY 14642, USA

2. Sex Hormone Research Center, China Medical University/Hospital, Taichung 404, Taiwan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CCL2-targeted ginkgolic acid exerts anti-glioblastoma effects by inhibiting the JAK3-STAT1/PI3K-AKT signaling pathway;Life Sciences;2022-12

2. Fibroblasts From Idiopathic Pulmonary Fibrosis Induce Apoptosis and Reduce the Migration Capacity of T Lymphocytes;Frontiers in Immunology;2022-02-10

3. Screening of anti‑chronic nonbacterial prostatitis activity of different extractions of the aerial part of Glycyrrhiza uralensis, and network pharmacology research;Biomedical Reports;2021-09-29

4. Encapsulation and Delivery of Dimethylcurcumin by Using Nanoparticles of a Polyethylene‐Glycol‐Based Dimethylcurcumin Prodrug;ChemistrySelect;2021-03-26

5. New therapy with XLQ ® to suppress chronic prostatitis through its anti‐inflammatory and antioxidative activities;Journal of Cellular Physiology;2019-02-20